Home
News
Press Releases and Articles
Calendar of Events
How to Help
Gates Foundation Grant to GAELF
The Global Alliance
Global Alliance History
Goals
Global Alliance Structure
Executive Group
Partnerships
GAELF Logo
LF Webring
About LF
What is LF?
How is LF Contracted?
How is LF Diagnosed?
Prevent/Eliminate LF
Manage LF
LF and Children
Additional Treatment Benefits
LF Slideshow
In Depth Disease Info
Where is LF?
Countries and Map List
Moving Forward
Starting Out
Success Stories
Progress and Plans
Elimination Strategy
Operational Research
Progress to Date
Economics of LF
Return on Investment
The Way Ahead
Highlighted Programmes
   Burkina Faso
   Sri Lanka

For the Media
Press Release Archive
Press Kits
Photos
Articles
Video Clips
Media Contacts
FAQs
Publications
LF News
Annual Reports
General Publications
Training Material
Videos
Journal Articles & Other Pubs
EG Updates
Gates Foundation

Sierra Leone
   

The goal of the National Programme to Eliminate Lymphatic Filariasis (NPELF) is to eliminate LF by 2013.

The World Health Organization (WHO) is the Secretariat of the Global Programme to Eliminate Lymphatic Filariasis and provides technical and financial support. Detailed information (endemicity, MDA, monitoring and evaluation) on this and other NPELF can be found on www.who.int/lymphatic_filariais.

   

Implementation of the NPELF

Click on map for full size version

MDA Treatments

 

 

MDA with Albendazole and Mectizan® only started in 2007 in 6 of the 14 IUs. Currently no treatment figures available.

 


Country data

Population

5,000,000

Endemicity

At risk population: 3,500,000. All 14 IUs (health districts) are endemic for LF

Clinical manifestations

Estimated that there are 100,000 hydrocoele cases and 20,000 have lymphoedema

Drug regime

Albendazole – donated by GlaxoSmithKline
Mectizan® - donated by Merck & Co. Inc.

MDA implementation cycle

MDA rounds from September to December annually

Treatment strategy

Door to Door. Drug distribution in schools only takes place in large towns and cities.

Social mobilisation

Radio discussions in all districts; airing of jingles on LF; community meetings with leaders and members of all targeted communities

Vector control

No programme

Co-implementation

Soil-Transmitted Helminths, Schistosomiasis, Guinea Worm, Onchocerciasis and Human African Trypanosomes

Recognition

Filaria species

 

Wuchereria bancrofti

Onchocerca volvulus

Loa loa

 

Mansonella perstans

 

Vectors

 

Anopheles gambiae complex   Simulium damnosum sl tick Culex quinquefasciatus tick Culicoides spp.  

An. funestus

 

S. naevis

 

 

 

 

 

Diagnostics

 

ICT tick Blood slide tick Skin snips tick Blood smears; Mazotti reaction  

Night blood smears

tick

REMO

 

Skin biopsies

 

Counting Chamber

 

Capacity Building

Year

Type of training

Number trained

2007

Managment and Diagnosis of LF (District Medical Officers)
6
Managment and Diagnosis of LF (Nurses/Medical Assistants)
150

Managment and Diagnosis of LF (Maternal and Child Health Aids)

350

Programme Support & Partnerships
The NPELF is included in both the national and district (IU) level budgets
Partners
Activities
Mapping
MDA
Social Mobilisation
Morbidity Management
Hydrocoele Surgery
Operational Research
Training
M&E Surveillance
Funding Partners
Mectizan Donation Program  
tick
tick
     
tick
tick
 
AFRO  
tick
tick
     
tick
tick
 
World Bank  
tick
       
tick
tick
 

Disability prevention programme
No disability plan in operation. Advocacy for disability management will be conducted in 2008.

Budget line
The MOH has no budget line for LF.This is because the LF programme is just starting as part of the Neglected Tropical Diseases (NTD) Control Programme and the MOH is yet to include a budget for NTDs in its National Plan and budget.

 

© Global Alliance to Eliminate Lymphatic Filariasis